Clinical and radiologic rebound after discontinuation of natalizumab therapy in a highly active multiple sclerosis patient was not halted by dimethyl-fumarate: a case report
Crossref DOI link: https://doi.org/10.1186/s12883-015-0512-0
Published Online: 2015-12-07
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Patti, Francesco
Leone, Carmela
Zappia, Mario